TITLE

Review: Angiotensin II receptor antagonists prevent headache in patients with mild-to-moderate hypertension

AUTHOR(S)
Bronson, David L.
PUB. DATE
January 2003
SOURCE
ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study which investigated the role of angiotensin II receptor anatagonists in preventing headache in patients with mild-to-moderate hypertension. Data sources; Selection of studies used as basis for the study; Results and findings.
ACCESSION #
9083222

 

Related Articles

  • Detection of Renovascular Hypertension with Angiotensin II Blockade. Baer, Leslie; Parra-Carrillo, Jose Z.; Radichevich, Ildiko; Williams, Gail S. // Annals of Internal Medicine;Mar77, Vol. 86 Issue 3, p257 

    Focuses on a study that analyzed the mechanisms of blood pressure regulation in renovascular hypertensive patients by competitive antagonism of angiotensin II using sarcosine-alanine-angiotensin II. Materials and methods; Results; Discussion.

  • Hypertension, Angiotensin II, and Oxidative Stress. Sowers, James R. // New England Journal of Medicine;6/20/2002, Vol. 346 Issue 25, p1999 

    Discusses hypertension, angiotensin II, and oxidative stress. How renovascular hypertension is a potentially curable form of secondary hypertension generally due to either atherosclerosis or fibromuscular dysplasia of one or both renal arteries; Evidence that suggests angiotensin II increases...

  • Erratum to "Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities".  // International Journal of Hypertension;2012, p1 

    Several corrections to the article "Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities" that was published in the 2012 issue is presented.

  • The development of Angiotensin II-induced hypertension during various salt intakes in Cre/lox conditional knockout mice for bradykinin receptors in distal tubule. Kopkan, L. // Proceedings of the Physiological Society;2014, p262P 

    An abstract of the article "The development of Angiotensin II-induced hypertension during various salt intakes in Cre/lox conditional knockout mice for bradykinin receptors in distal tubule" by L. Kopkan is presented.

  • Hypertension, Platelets, and Inflammatory Responses. Opie, L. // Cardiovascular Drugs & Therapy;Jun2014, Vol. 28 Issue 3, p291 

    A letter to the editor is presented in response to the article "Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis," by L.X. Jia and colleagues in issue number 2013; 27: 521-530.

  • Antihypertensive drugs help prevent headaches.  // BMJ: British Medical Journal (International Edition);12/10/2005, Vol. 331 Issue 7529, p1349 

    The article discusses the results of a study related to the association of high blood pressure with headache. Antihypertensive drugs were found to reduce the occurrence of headache when compared to placebo. The methods used in the study included a systematic search of controlled trials which...

  • Hypertension -- Treatment.  // Current Medical Literature: Nephrology & Hypertension;2006, Vol. 12 Issue 3, p96 

    The article presents information on various studies about the treatment of hypertension. A study compares the control of hypertension and the risk of adverse clinical outcomes in Hispanic individuals and non-Hispanic individuals enrolled in International Verapamil-Trandolapril Study. One study...

  • Effects of allisartan, a new AT1 receptor blocker, on blood pressure and end-organ damage in hypertensive animals. Ming-yue WU; Xiu-juan MA; Chu YANG; Xia TAO; Ai-jun LIU; Ding-feng SU; Jian-guo LIU // Acta Pharmacologica Sinica;Mar2009, Vol. 30 Issue 3, p307 

    AbstractAim:To investigate the effects of allisartan, a new angiotensin II type 1 (AT1) receptor antagonist, on blood pressure (BP) and end-organ damage (EOD) in hypertensive rats and dogs.Methods:First, a single dose of allisartan was given intragastrically to evaluate the BP reduction in...

  • Angiotensin Blockade in Hypertension. Streeten, David H. P.; Anderson, Gunnar H. // Annals of Internal Medicine;Mar77, Vol. 86 Issue 3, p353 

    Editorial. Comments on the excessive angiotensin II activity as the cause of some types of hypertension in human. Details of the report on the blood pressure responses of several hypertensive patients; Saralasin as a competitive antagonist of the action of angiotensin II; Contribution of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics